Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray

scientific article published on 20 November 2017

Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41431-017-0020-3
P932PMC publication ID5865210
P698PubMed publication ID29158552

P50authorStephen W. SchererQ7610775
Michael BrudnoQ63815290
Jasmin BhawraQ76444622
P2093author name stringChristian R Marshall
Cheryl Shuman
Sarah Bowdin
Shinya Ito
M Stephen Meyn
Wendy J Ungar
Robin Z Hayeems
Raveen Basran
Iris Cohn
Nasim Monfared
Ronald D Cohn
Marta Girdea
D James Stavropoulos
Courtney Hum
Kate Tsiplova
P2860cites workAssessing the Costs and Cost-Effectiveness of Genomic SequencingQ26774155
Beyond diagnostic accuracy: the clinical utility of diagnostic testsQ27004609
Human genome sequencing using unchained base reads on self-assembling DNA nanoarraysQ28263829
Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel diseaseQ28301461
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debateQ28661760
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataQ29547161
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics supportQ29547407
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicineQ30585056
Whole Genome Sequencing Expands Diagnostic Utility and Improves Clinical Management in Pediatric MedicineQ33736038
Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practiceQ34157264
Genome sequencing identifies major causes of severe intellectual disabilityQ34422838
Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care unitsQ34820081
The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary diseaseQ34865360
Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disordersQ34866575
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.Q35205646
Whole-genome sequencing for optimized patient managementQ35857612
Patterns and costs of health care use of children with medical complexityQ35926490
Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarrayQ35959752
Costs of the diagnostic odyssey in children with inherited leukodystrophiesQ36156645
Early Stage Health Technology Assessment for Precision Biomarkers in Oral Health and Systems MedicineQ36538793
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?Q37029751
Implementing genomic medicine in the clinic: the future is hereQ37328458
Chromosomal microarray testing influences medical managementQ37895879
Assessing the value of diagnostic tests: a framework for designing and evaluating trialsQ37987071
The promise and challenges of next-generation genome sequencing for clinical careQ38161772
The genome clinic: a multidisciplinary approach to assessing the opportunities and challenges of integrating genomic analysis into clinical care.Q38193764
The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.Q38392363
PhenoTips: patient phenotyping software for clinical and research use.Q38490526
A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorderQ38687777
The diagnostic pathway in complex paediatric neurology: a cost analysisQ41554178
Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.Q47681796
Test Pricing and Reimbursement in Genomic Medicine: Towards a General StrategyQ49024578
How physicians use array comparative genomic hybridization results to guide patient management in children with developmental delayQ50133817
The impact of chromosomal microarray on clinical management: a retrospective analysisQ50308309
American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variantsQ50310344
The usefulness of whole-exome sequencing in routine clinical practice.Q50657606
Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and GenomicsQ86912988
P433issue12
P921main subjectwhole genome sequencingQ2068526
P304page(s)1303-1312
P577publication date2017-11-20
P1433published inEuropean Journal of Human GeneticsQ2155433
P1476titleCare and cost consequences of pediatric whole genome sequencing compared to chromosome microarray
P478volume25

Reverse relations

cites work (P2860)
Q99609303A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysis
Q101039017Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies
Q58436885Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness
Q89081828Genome-wide sequencing in acutely ill infants: genomic medicine's critical application?
Q93020577Juvenile idiopathic arthritis associated with a mutation in GATA3
Q64039263Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes
Q52592806Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization.

Search more.